These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 15809819)

  • 1. Treatment with B-type natriuretic peptide for chronic decompensated heart failure: insights learned from the follow-up serial infusion of nesiritide (FUSION) trial.
    Yancy CW
    Heart Fail Rev; 2004 Jul; 9(3):209-16. PubMed ID: 15809819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and efficacy of outpatient nesiritide in patients with advanced heart failure: results of the Second Follow-Up Serial Infusions of Nesiritide (FUSION II) trial.
    Yancy CW; Krum H; Massie BM; Silver MA; Stevenson LW; Cheng M; Kim SS; Evans R;
    Circ Heart Fail; 2008 May; 1(1):9-16. PubMed ID: 19808265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and feasibility of using serial infusions of nesiritide for heart failure in an outpatient setting (from the FUSION I trial).
    Yancy CW; Saltzberg MT; Berkowitz RL; Bertolet B; Vijayaraghavan K; Burnham K; Oren RM; Walker K; Horton DP; Silver MA
    Am J Cardiol; 2004 Sep; 94(5):595-601. PubMed ID: 15342289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential applications of outpatient nesiritide infusions in patients with advanced heart failure and concomitant renal insufficiency (from the Follow-Up Serial Infusions of Nesiritide [FUSION I] trial).
    Yancy CW; Singh A
    Am J Cardiol; 2006 Jul; 98(2):226-9. PubMed ID: 16828598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Second Follow-up Serial Infusions of Nesiritide (FUSION II) trial for advanced heart failure: study rationale and design.
    Yancy CW; Krum H; Massie BM; Silver MA; Stevenson LW; Cheng M; Kim SS; Evans R;
    Am Heart J; 2007 Apr; 153(4):478-84. PubMed ID: 17383282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy and safety of B-type natriuretic peptide (nesiritide) in patients with renal insufficiency and acutely decompensated congestive heart failure.
    Butler J; Emerman C; Peacock WF; Mathur VS; Young JB;
    Nephrol Dial Transplant; 2004 Feb; 19(2):391-9. PubMed ID: 14736964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained hemodynamic effects of an infusion of nesiritide (human b-type natriuretic peptide) in heart failure: a randomized, double-blind, placebo-controlled clinical trial. Natrecor Study Group.
    Mills RM; LeJemtel TH; Horton DP; Liang C; Lang R; Silver MA; Lui C; Chatterjee K
    J Am Coll Cardiol; 1999 Jul; 34(1):155-62. PubMed ID: 10400005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nesiritide: a review of its use in acute decompensated heart failure.
    Keating GM; Goa KL
    Drugs; 2003; 63(1):47-70. PubMed ID: 12487622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acutely decompensated heart failure in a county emergency department: a double-blind randomized controlled comparison of nesiritide versus placebo treatment.
    Miller AH; Nazeer S; Pepe P; Estes B; Gorman A; Yancy CW
    Ann Emerg Med; 2008 May; 51(5):571-8. PubMed ID: 18304693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of standard heart failure therapy and concomitant treatment with intravenous furosemide or inotropes (dobutamine, dopamine, and/or milrinone) on renal function and mortality in patients treated with nesiritide.
    Kurien S; Warfield KT; Wood CM; Miller WL
    Am J Cardiol; 2006 Dec; 98(12):1627-30. PubMed ID: 17145223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nesiritide for the treatment of decompensated heart failure.
    Wylie JV; Tsao L
    Expert Rev Cardiovasc Ther; 2004 Nov; 2(6):803-13. PubMed ID: 15500426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Canadian context for the Acute Study of Clinical Effectiveness of Nesiritide and Decompensated Heart Failure (ASCEND-HF) trial.
    Armstrong PW; Rouleau JL
    Can J Cardiol; 2008 Jul; 24 Suppl B(Suppl B):30B-2B. PubMed ID: 18629387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of intravenous nesiritide on pulmonary vascular hemodynamics in pulmonary hypertension.
    Michaels AD; Chatterjee K; De Marco T
    J Card Fail; 2005 Aug; 11(6):425-31. PubMed ID: 16105633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of nesiritide on renal function in patients with acute decompensated heart failure and pre-existing renal dysfunction a randomized, double-blind, placebo-controlled clinical trial.
    Witteles RM; Kao D; Christopherson D; Matsuda K; Vagelos RH; Schreiber D; Fowler MB
    J Am Coll Cardiol; 2007 Nov; 50(19):1835-40. PubMed ID: 17980248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rationale, design, and methods for the Transplant-Eligible MAnagement of Congestive Heart Failure (TMAC) trial: a multicenter clinical outcomes trial using nesiritide for TMAC.
    Mehra MR; McCluskey T; Barr M; Bourge RC; Jessup ML; Mancini D; Radovancevic B; Rayburn B; Taylor DO; Lilly-Hersley J; Linde P
    Am Heart J; 2007 Jun; 153(6):932-40. PubMed ID: 17540193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B-type natriuretic peptide infusions in acute myocardial infarction.
    Hillock RJ; Frampton CM; Yandle TG; Troughton RW; Lainchbury JG; Richards AM
    Heart; 2008 May; 94(5):617-22. PubMed ID: 17639095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group.
    Colucci WS; Elkayam U; Horton DP; Abraham WT; Bourge RC; Johnson AD; Wagoner LE; Givertz MM; Liang CS; Neibaur M; Haught WH; LeJemtel TH
    N Engl J Med; 2000 Jul; 343(4):246-53. PubMed ID: 10911006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mode of death and hospitalization from the Second Follow-up Serial Infusions of Nesiritide (FUSION II) trial and comparison of clinical events committee adjudicated versus investigator reported outcomes.
    O'Connor CM; Fiuzat M; Lindenfeld J; Miller A; Lombardi C; Carson P; Shaw LK; Wang LJ; Connolly P; Mills R; Yancy C; Mahaffey K
    Am J Cardiol; 2011 Nov; 108(10):1449-57. PubMed ID: 21890092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nesiritide does not improve renal function in patients with chronic heart failure and worsening serum creatinine.
    Wang DJ; Dowling TC; Meadows D; Ayala T; Marshall J; Minshall S; Greenberg N; Thattassery E; Fisher ML; Rao K; Gottlieb SS
    Circulation; 2004 Sep; 110(12):1620-5. PubMed ID: 15337695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Observation unit treatment of heart failure with nesiritide: results from the proaction trial.
    Peacock WF; Holland R; Gyarmathy R; Dunbar L; Klapholz M; Horton DP; de Lissovoy G; Emerman CL
    J Emerg Med; 2005 Oct; 29(3):243-52. PubMed ID: 16183441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.